| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 203 companies in the Health Care Equipment & Supplies industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 9, 2022 | EW Edwards Lifesciences Corp | Bobo Donald E Jr64 | Cvp,Strategy/ Corp Development | Sell | 6,725 | $105.01 | $706,192.25 | -9.7% | -32.2% | -23.1% | |
| Aug 9, 2022 | BDX Becton Dickinson & Co | Polen Thomas E Jr | Executive Vice President | Sell | 1,652 | $260.00 | $429,520.00 | -5.4% | -13.2% | +11.9% | |
| Aug 9, 2022 | EW Edwards Lifesciences Corp | Wood Larry L67 | Cvp, Tavr | Sell | 7,242 | $104.71 | $758,304.02 | -1.7% | -32.2% | -23.1% | |
| Aug 8, 2022 | CTKB Cytek Biosciences, Inc. | Jiang Wenbin75 | President And CEO | Sell | 20,000 | $15.09 | $301,800.00 | -0.3% | -2.2% | -40.7% | |
| Aug 8, 2022 | TCMD Tactile Systems Technology Inc | Reuvers Daniel L.67 | President And CEO | Sell | 1,020 | $9.18 | $9,363.70 | -1.3% | -23.9% | +95.0% | |
| Aug 8, 2022 | ENOV Enovis Corp | Tandy Bradley J65 | SVP, General Counsel | Sell | 3,355 | $58.39 | $195,898.45 | -19.5% | -8.3% | -0.6% | |
| Aug 8, 2022 | OM Outset Medical, Inc. | Ahmed Nabeel84 | Chief Financial Officer | Sell | 1,048 | $19.25 | $20,174.00 | -2.4% | -38.7% | -18.5% | |
| Aug 8, 2022 | BSX Boston Scientific Corp | Mahoney Michael F57 | Chairman, President &CEO | Sell | 125,828 | $40.97 | $5,154,682.43 | -5.6% | +2.4% | +23.5% | |
| Aug 8, 2022 | TMDX Transmedics Group, Inc. | Gordon Stephen52 | Chief Financial Officer | Sell | 10,000 | $48.09 | $480,900.00 | -63.6% | +25.7% | +44.0% | |
| Aug 8, 2022 | MASS 908 Devices Inc. | Knopp Kevin J.79 | President And CEO | Sell | 26,196 | $25.32 | $663,239.82 | -2.2% | -33.3% | -64.3% | |
| Aug 8, 2022 | AXGN Axogen, Inc. | Freitag Gregory Gene68 | Director | Sell | 37,046 | $10.54 | $390,647.02 | -4.6% | +2.8% | -35.8% | |
| Aug 5, 2022 | TMDX Transmedics Group, Inc. | Khayal Tamer I53 | Chief Commercial Officer | Sell | 20,000 | $45.12 | $902,400.00 | -35.7% | -7.5% | +64.5% | |
| Aug 5, 2022 | IART Integra Lifesciences Holdings Corp | Murphy Raymond G. | Director | Sell | 8,000 | $55.78 | $446,266.40 | -16.4% | -12.5% | -19.5% | |
| Aug 5, 2022 | MYO Myomo, Inc. | Crowley Thomas Aloysius Jr.80 | Director | Sell | 7,141 | $1.71 | $12,218.25 | -35.6% | -18.8% | -60.7% | |
| Aug 5, 2022 | TMDX Transmedics Group, Inc. | Hassanein Waleed H56 | President &CEO | Sell | 20,000 | $45.13 | $902,600.00 | -3.8% | -7.5% | +64.5% | |
| Aug 5, 2022 | EW Edwards Lifesciences Corp | Zovighian Bernard J55 | Cvp, Tmtt | Sell | 4,811 | $103.66 | $498,708.26 | -18.5% | -35.3% | -25.0% | |
| Aug 5, 2022 | GKOS Glaukos Corp | Kliman Gilbert H64 | Director | Sell | 3,362 | $53.01 | $178,229.37 | -100% | -8.9% | +40.5% | |
| Aug 5, 2022 | TMCI Treace Medical Concepts, Inc. | Timbie Thomas E69 | Director | Sell | 150,000 | $18.76 | $2,813,965.77 | -3.2% | +12.3% | +6.0% | |
| Aug 4, 2022 | IRMD Iradimed Corp | Allen Monty K46 | - | Sell | 3,072 | $37.71 | $115,845.43 | -15.4% | -27.6% | +28.5% | |
| Aug 4, 2022 | TCMD Tactile Systems Technology Inc | Burke William W75 | Director | Buy | 4,900 | $9.15 | $44,835.00 | +25.1% | -24.4% | +131.3% | |
| Aug 4, 2022 | RGEN Repligen Corp | Gebski Christine62 | See Remarks | Sell | 3,357 | $243.01 | $815,784.57 | -9.8% | -29.5% | -29.0% | |
| Aug 4, 2022 | SENS Senseonics Holdings, Inc. | Jain Mukul77 | Chief Operating Officer | Sell | 50,000 | $1.97 | $98,500.00 | -2.0% | -42.9% | -58.1% | |
| Aug 4, 2022 | STSS Sharps Technology Inc. | Hayes Robert Michael | Chief Executive Officer | Buy | 2,000 | $1.15 | $2,290.00 | +3.3% | +1.7% | -24.4% | |
| Aug 4, 2022 | MASS 908 Devices Inc. | Griffith Joseph H. IV81 | Chief Financial Officer | Sell | 13,333 | $24.39 | $325,131.87 | -6.8% | -40.3% | -74.6% | |
| Aug 4, 2022 | LAB Standard Biotools Inc. | Caligan Partners LP58 | 10% Owner | Buy | 301,182 | $1.75 | $526,608.41 | +1.3% | -33.3% | +43.5% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.